Hyperaldosteronism is associated with impaired vascular reactivity, and it has been shown that aldosterone induces a G6PD-deficient phenotype to impair endothelial function, and aldosterone antagonism or gene transfer of G6PD improves vascular reactivity [9]
It is designed for once-weekly subcutaneous administration [16, 17]
This direct delivery means your body can use the vitamin immediately, unlike oral supplements that need to be digested and absorbed
We caught our Client Advocate mid-injection: BPC-157 This powerful peptide is known for its potential benefits in accelerating recovery, reducing inflammation, healing injuries, and even supporting gut health
Compounding BPC-157: A regulatory loophole In a statement, Health Canada said BPC157 has not been authorized, its safety, efficacy, and quality have not been assessed and there is limited scientific evidence to support its use, including a lack of established human dosing protocols